Telemedically Assisted Optimization for Heart Failure Patients Before Cardiac Surgery to Improve Perioperative Outcome
PREPARE-HF
Prospective, Randomized Open Label Trial of Telemedically Assisted Optimization for Heart Failure Patients Before Cardiac Surgery to Improve Perioperative Outcome
1 other identifier
interventional
162
1 country
1
Brief Summary
Patients with heart failure undergoing cardiac surgery face a significantly increased perioperative risk, yet no standardized strategy exists to mitigate this risk effectively. Current preoperative management relies on optimization of medical therapy without a structured prehabilitation approach. Given the strong association between eleveated preoperative N-terminal pro-B-type natriuretic peptide levels and postoperative outcomes, patients at increased risk could be identified using this biomarker. Telemedical disease management programs have demonstrated efficacy in outpatient heart failure care, but their role in preoperative optimization remains underexplored. This study aims to assess whether a structured, multidisciplinary, telemedicine-assisted prehabilitation program can reduce perioperative complications, and improve surgical outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2026
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 7, 2026
CompletedFirst Posted
Study publicly available on registry
February 6, 2026
CompletedStudy Start
First participant enrolled
February 16, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 16, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2034
February 18, 2026
December 1, 2025
3.2 years
January 7, 2026
February 17, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Hierachical Endpoint Perioperative Outcome: 30-day mortality
All-cause mortality from randomization to 30 days post-surgery
assessed from randomization through 30 days post-surgery,
Hierachical Endpoint Perioperative Outcome: ECMO
Requirement for extracorporeal membrane oxygenation (ECMO) within 30 days post-surgery
assessed from surgery until 30 days post-surgery
Hierachical Endpoint Perioperative Outcome: hemodialysis or ultrafiltration
Need for hemodialysis or ultrafiltration within 30 days post-surgery
assessed from surgery until 30 days post-surgery
Hierachical Endpoint Perioperative Outcome: stay on ICU
Length of stay in the intensive care unit (ICU) within 30 days post-surgery
assessed from surgery until 30 days post-surgery.
Secondary Outcomes (22)
Preoperative adverse events: death
will be assessed on day prior to surgery
Preoperative adverse events: hospitalization
will be assessed on day prior to surgery
Preoperative adverse events: urgent surgery necessary
will be assessed on day prior to surgery
Perioperative outcome: 30-day mortality
will be assessed on day 30 after surgery
Perioperative outcome: ECMO
will be assessed on day 30 after surgery
- +17 more secondary outcomes
Other Outcomes (6)
Safety endpoint: Hyperkalemia
from randomization to day prior to surgery
Safety endpoint: Acute kidney injury
from randomization to day prior to surgery
Safety endpoint: Syncope
from randomization to day prior to surgery
- +3 more other outcomes
Study Arms (2)
Control arm - Standard of care treatment
NO INTERVENTIONReceives standard preoperative care until surgery.
PREPARE-HF
EXPERIMENTALPreoperative Heart Failure Optimization and Telemedicine Integration
Interventions
1. Heart failure education and training 2. Optimization of guideline-directed medical therapy (GDMT) 3. Telemedical / telenursing / monitoring and therapy adjustments 4. Supervised telemedicine-assisted exercise program
Eligibility Criteria
You may qualify if:
- Indication for elective cardiac surgery in the Heart team
- NTproBNP ≥ 1500 ng/L
- ≥ 18 years willing to participate in trial
- Written informed consent
You may not qualify if:
- Neuropsychiatric disorders / illnesses (e.g. drug addiction, alcohol abuse) that do not allow adherent participation in the study
- No sufficient ability to measure and transfer data or existing support in the social environment
- no sufficient ability to communicate (language skills, eyesight, hearing)
- Pregnancy
- Chronic kidney disease requiring dialysis
- Planed procedure: heart transplantation (HTX), implant of left ventricular mechanical assist devices (L-VAD)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medical University of Innsbruck - Department of Cardiology & Department of Cardiac Surgery
Innsbruck, Tyrol, 6020, Austria
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Can Gollmann-Tepeköylü, Prof.
Medical University of Innsbruck - Department of cardiac surgery
- PRINCIPAL INVESTIGATOR
Gerhard Pölzl, Prof.
Medical University of Innsbruck - Department of cardiology
- PRINCIPAL INVESTIGATOR
Christian Puelacher, MD
Medical University of Innsbruck - Department of cardiology
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Blinding is not feasible because the intervention involves overt telemedical monitoring, patient education, and individualized therapeutic adjustments that are readily apparent to both patients and healthcare providers, necessitating an open-label study design.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 7, 2026
First Posted
February 6, 2026
Study Start
February 16, 2026
Primary Completion (Estimated)
April 16, 2029
Study Completion (Estimated)
January 1, 2034
Last Updated
February 18, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- following publication of primary and secondary results
- Access Criteria
- Data will be shared upon reasonable request.